• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Congenital Long QT syndrome and torsade de pointes.先天性长QT综合征与尖端扭转型室速
Ann Noninvasive Electrocardiol. 2017 Nov;22(6). doi: 10.1111/anec.12481. Epub 2017 Jul 2.
2
Acquired long QT syndrome and torsade de pointes.获得性长QT综合征与尖端扭转型室速。
Pacing Clin Electrophysiol. 2018 Apr;41(4):414-421. doi: 10.1111/pace.13296. Epub 2018 Mar 30.
3
The long QT syndrome and torsade de pointes.长QT综合征与尖端扭转型室性心动过速。
Pacing Clin Electrophysiol. 1999 Jan;22(1 Pt 1):91-110. doi: 10.1111/j.1540-8159.1999.tb00305.x.
4
A new biomarker--index of cardiac electrophysiological balance (iCEB)--plays an important role in drug-induced cardiac arrhythmias: beyond QT-prolongation and Torsades de Pointes (TdPs).一种新的生物标志物——心脏电生理平衡指数(iCEB)——在药物诱发的心律失常中发挥着重要作用:超越QT间期延长和尖端扭转型室性心动过速(TdP)。
J Pharmacol Toxicol Methods. 2013 Sep-Oct;68(2):250-259. doi: 10.1016/j.vascn.2013.01.003. Epub 2013 Jan 19.
5
Genetic and clinical advances in congenital long QT syndrome.先天性长QT综合征的遗传学与临床进展
Circ J. 2014;78(12):2827-33. doi: 10.1253/circj.cj-14-0905. Epub 2014 Oct 1.
6
Cellular basis for long QT, transmural dispersion of repolarization, and torsade de pointes in the long QT syndrome.长QT综合征中长QT间期、复极跨壁离散度及尖端扭转型室速的细胞基础
J Electrocardiol. 1999;32 Suppl:177-84. doi: 10.1016/s0022-0736(99)90077-8.
7
Electrophysiologic mechanisms of the long QT interval syndromes and torsade de pointes.长QT间期综合征和尖端扭转型室速的电生理机制
Ann Intern Med. 1995 May 1;122(9):701-14. doi: 10.7326/0003-4819-122-9-199505010-00009.
8
Cellular and ionic mechanism for drug-induced long QT syndrome and effectiveness of verapamil.药物诱导长QT综合征的细胞和离子机制及维拉帕米的有效性
J Am Coll Cardiol. 2005 Jan 18;45(2):300-7. doi: 10.1016/j.jacc.2004.09.069.
9
Torsade de pointes: the clinical considerations.尖端扭转型室性心动过速:临床考量
Int J Cardiol. 2004 Jul;96(1):1-6. doi: 10.1016/j.ijcard.2003.04.055.
10
Effects of a K(+) channel opener to reduce transmural dispersion of repolarization and prevent torsade de pointes in LQT1, LQT2, and LQT3 models of the long-QT syndrome.钾通道开放剂对减少复极跨壁离散度及预防长QT综合征LQT1、LQT2和LQT3模型中尖端扭转型室速的作用。
Circulation. 2000 Aug 8;102(6):706-12. doi: 10.1161/01.cir.102.6.706.

引用本文的文献

1
Cardiac Channelopathies: Clinical Diagnosis and Promising Therapeutics.心脏离子通道病:临床诊断与前景广阔的治疗方法
J Am Heart Assoc. 2025 May 6;14(9):e040072. doi: 10.1161/JAHA.124.040072. Epub 2025 Apr 25.
2
Case report: A 56-year-old woman presenting with torsades de pointes and cardiac arrest associated with levosimendan administration and underlying congenital long QT syndrome type 1.病例报告:一名56岁女性,出现尖端扭转型室速和心脏骤停,与使用左西孟旦及潜在的先天性1型长QT综合征相关。
Heliyon. 2024 Apr 10;10(8):e29300. doi: 10.1016/j.heliyon.2024.e29300. eCollection 2024 Apr 30.
3
Whole exome sequencing in Brugada and long QT syndromes revealed novel rare and potential pathogenic mutations related to the dysfunction of the cardiac sodium channel.全外显子组测序在 Brugada 和长 QT 综合征中发现了与心脏钠离子通道功能障碍相关的新型罕见和潜在致病性突变。
Orphanet J Rare Dis. 2022 Oct 27;17(1):394. doi: 10.1186/s13023-022-02542-z.
4
High-altitude Hypoxia Influences the Activities of the Drug-Metabolizing Enzyme CYP3A1 and the Pharmacokinetics of Four Cardiovascular System Drugs.高原低氧对药物代谢酶CYP3A1活性及四种心血管系统药物药代动力学的影响。
Pharmaceuticals (Basel). 2022 Oct 21;15(10):1303. doi: 10.3390/ph15101303.
5
Racial Disparities in Ion Channelopathies and Inherited Cardiovascular Diseases Associated With Sudden Cardiac Death.种族差异与离子通道病和遗传性心血管疾病相关的心脏性猝死。
J Am Heart Assoc. 2022 Mar 15;11(6):e023446. doi: 10.1161/JAHA.121.023446. Epub 2022 Mar 4.
6
Transient Hypogonadism Is Associated With Heart Rate-Corrected QT Prolongation and Torsades de Pointes Risk During Active Systemic Inflammation in Men.男性在系统性炎症活动期时,短暂性性腺功能减退与心率校正 QT 间期延长和尖端扭转型室性心动过速风险相关。
J Am Heart Assoc. 2022 Jan 4;11(1):e023371. doi: 10.1161/JAHA.121.023371. Epub 2021 Dec 22.
7
A Systematic Review on the Role of Βeta-Blockers in Reducing Cardiac Arrhythmias in Long QT Syndrome Subtypes 1-3.β受体阻滞剂在降低长QT综合征1-3型心律失常中作用的系统评价
Cureus. 2021 Sep 1;13(9):e17632. doi: 10.7759/cureus.17632. eCollection 2021 Sep.
8
Remodeling of Ion Channel Trafficking and Cardiac Arrhythmias.离子通道运输重构与心律失常。
Cells. 2021 Sep 14;10(9):2417. doi: 10.3390/cells10092417.
9
Anti-Ro/SSA Antibodies and the Autoimmune Long-QT Syndrome.抗Ro/SSA抗体与自身免疫性长QT综合征
Front Med (Lausanne). 2021 Sep 6;8:730161. doi: 10.3389/fmed.2021.730161. eCollection 2021.
10
Prediction of arrhythmia susceptibility through mathematical modeling and machine learning.通过数学建模和机器学习预测心律失常易感性。
Proc Natl Acad Sci U S A. 2021 Sep 14;118(37). doi: 10.1073/pnas.2104019118.

本文引用的文献

1
The genetics underlying acquired long QT syndrome: impact for genetic screening.获得性长QT综合征的遗传学基础:对基因筛查的影响
Eur Heart J. 2016 May 7;37(18):1456-64. doi: 10.1093/eurheartj/ehv695. Epub 2015 Dec 28.
2
Role of pharmacotherapy in cardiac ion channelopathies.心脏离子通道病的药物治疗作用。
Pharmacol Ther. 2015 Nov;155:132-42. doi: 10.1016/j.pharmthera.2015.09.002. Epub 2015 Sep 12.
3
Pharmacogenetics of Drug-Induced QT Interval Prolongation: An Update.药物诱导的QT间期延长的药物遗传学:最新进展
Drug Saf. 2015 Oct;38(10):855-67. doi: 10.1007/s40264-015-0316-6.
4
Genetic and clinical advances in congenital long QT syndrome.先天性长QT综合征的遗传学与临床进展
Circ J. 2014;78(12):2827-33. doi: 10.1253/circj.cj-14-0905. Epub 2014 Oct 1.
5
Induced pluripotent stem cells for the study of cardiovascular disease.诱导多能干细胞在心血管疾病研究中的应用。
J Am Coll Cardiol. 2014 Aug 5;64(5):512-9. doi: 10.1016/j.jacc.2014.05.038.
6
Genotype- and phenotype-guided management of congenital long QT syndrome.基于基因型和表型的先天性长 QT 综合征管理。
Curr Probl Cardiol. 2013 Oct;38(10):417-55. doi: 10.1016/j.cpcardiol.2013.08.001.
7
Identification of a KCNQ1 polymorphism acting as a protective modifier against arrhythmic risk in long-QT syndrome.鉴定一种作为长QT综合征心律失常风险保护性修饰因子的KCNQ1基因多态性。
Circ Cardiovasc Genet. 2013 Aug;6(4):354-61. doi: 10.1161/CIRCGENETICS.113.000023. Epub 2013 Jul 15.
8
Genetics of congenital and drug-induced long QT syndromes: current evidence and future research perspectives.先天性和药物性长QT综合征的遗传学:当前证据与未来研究展望
J Interv Card Electrophysiol. 2013 Jun;37(1):9-19. doi: 10.1007/s10840-013-9779-5. Epub 2013 Mar 21.
9
Risk of life-threatening cardiac events among patients with long QT syndrome and multiple mutations.长 QT 综合征伴多种突变患者发生危及生命的心脏事件的风险。
Heart Rhythm. 2013 Mar;10(3):378-82. doi: 10.1016/j.hrthm.2012.11.006. Epub 2012 Nov 19.
10
Not all beta-blockers are equal in the management of long QT syndrome types 1 and 2: higher recurrence of events under metoprolol.并非所有β受体阻滞剂在 1 型和 2 型长 QT 综合征的管理中都具有同等作用:美托洛尔的事件复发率更高。
J Am Coll Cardiol. 2012 Nov 13;60(20):2092-9. doi: 10.1016/j.jacc.2012.07.046. Epub 2012 Oct 17.

先天性长QT综合征与尖端扭转型室速

Congenital Long QT syndrome and torsade de pointes.

作者信息

El-Sherif Nabil, Turitto Gioia, Boutjdir Mohamed

机构信息

Downstate Medical Center, State University of New York, Brooklyn, NY, USA.

VA NY Harbor Healthcare System, Brooklyn, NY, USA.

出版信息

Ann Noninvasive Electrocardiol. 2017 Nov;22(6). doi: 10.1111/anec.12481. Epub 2017 Jul 2.

DOI:10.1111/anec.12481
PMID:28670758
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6931590/
Abstract

Since its initial description by Jervell and Lange-Nielsen in 1957, the congenital long QT syndrome (LQTS) has been the most investigated cardiac ion channelopathy. A prolonged QT interval in the surface electrocardiogram is the sine qua non of the LQTS and is a surrogate measure of the ventricular action potential duration (APD). Congenital as well as acquired alterations in certain cardiac ion channels can affect their currents in such a way as to increase the APD and hence the QT interval. The inhomogeneous lengthening of the APD across the ventricular wall results in dispersion of APD. This together with the tendency of prolonged APD to be associated with oscillations at the plateau level, termed early afterdepolarizations (EADs), provides the substrate of ventricular tachyarrhythmia associated with LQTS, usually referred to as torsade de pointes (TdP) VT. This review will discuss the genetic, molecular, and phenotype characteristics of congenital LQTS as well as current management strategies and future directions in the field.

摘要

自1957年耶尔韦尔(Jervell)和朗格 - 尼尔森(Lange-Nielsen)首次描述先天性长QT综合征(LQTS)以来,它一直是研究最多的心脏离子通道病。体表心电图QT间期延长是LQTS的必要条件,也是心室动作电位时程(APD)的替代指标。某些心脏离子通道的先天性以及后天性改变可影响其电流,从而增加APD,进而延长QT间期。整个心室壁APD的不均匀延长导致APD离散。这与延长的APD易于在平台期出现振荡(即早期后除极,EADs)的倾向一起,为与LQTS相关的室性快速性心律失常提供了基础,通常称为尖端扭转型室速(TdP)。本综述将讨论先天性LQTS的遗传、分子和表型特征,以及该领域目前的管理策略和未来方向。